Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

E. coli Meningitis.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.

Lancet (London, England)·2025
Same author

Impact of central adjudication of the score on the modified Rankin Scale in an international, randomized, acute stroke trial.

European stroke journal·2025
Same author

Exploring Skin Pigmentation Adaptation: A Systematic Review on the Vitamin D Adaptation Hypothesis.

Cutis·2024
Same author

Cerebral Small Vessel Disease and Infarct Growth in Acute Ischemic Stroke Treated with Intravenous Thrombolysis.

Translational stroke research·2024
Same author

Ferroptosis in Cardiovascular Disease and Cardiomyopathies: Therapeutic Implications of Glutathione and Iron Chelating Agents.

Biomedicines·2024
Same journal

Association of revascularization strategy with wound healing following toe amputation in chronic limb-threatening ischemia.

Journal of vascular surgery·2026
Same journal

Premature peripheral arterial disease (PAD) is associated with worse outcomes after endovascular peripheral vascular intervention.

Journal of vascular surgery·2026
Same journal

Self-Expandable versus Balloon-Expandable Bridging Stents in Off-the-Shelf Inner Branch Repair: Midterm Results from the INBREED Registry.

Journal of vascular surgery·2026
Same journal

Procedural outcomes and follow-up of endovascular treatment for extracranial carotid artery aneurysms; a systematic review.

Journal of vascular surgery·2026
Same journal

Impact of Insurance Status on Urgency of Presentation and Perioperative Outcomes Following Endovascular Repair of Abdominal Aortic Aneurysms: A Vascular Quality Initiative Analysis.

Journal of vascular surgery·2026
Same journal

Large language models routinely overcode peripheral endovascular procedures relative to professional coders.

Journal of vascular surgery·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Thrombolysis for acute ischemic stroke.

Karim Hajjar1, Daniel M Kerr, Kennedy R Lees

  • 1Department of Stroke Research, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

Journal of Vascular Surgery
|September 6, 2011
PubMed
Summary
This summary is machine-generated.

Rapid administration of intravenous alteplase for acute ischemic stroke is crucial for improving outcomes. Delays beyond 4.5 hours increase mortality and negate the treatment benefits.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

Related Experiment Videos

Last Updated: May 29, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

Area of Science:

  • Neurology
  • Emergency Medicine
  • Pharmacology

Background:

  • Intravenous alteplase is the standard treatment for acute ischemic stroke.
  • Treatment efficacy is highly time-dependent, with benefits diminishing after 4.5 hours.
  • Symptomatic intracranial hemorrhage (SICH) is a known risk, occurring in approximately 3% of patients.

Purpose of the Study:

  • To review the efficacy and safety of intravenous alteplase for acute ischemic stroke.
  • To emphasize the critical importance of early treatment initiation.
  • To discuss factors influencing treatment outcomes and subgroup effectiveness.

Main Methods:

  • Review of randomized controlled trials and pooled analyses of intravenous thrombolysis.
  • Analysis of secondary data and controlled registry data.
  • Evaluation of treatment risks, including bleeding complications.

Main Results:

  • Intravenous alteplase demonstrates significant benefit when administered within 4.5 hours of stroke onset.
  • Earlier treatment is associated with greater functional outcome improvement.
  • Alteplase remains effective in most patient subgroups, despite factors like stroke severity and age.

Conclusions:

  • Early administration of intravenous alteplase is paramount for optimizing outcomes in acute ischemic stroke.
  • Awareness of the time-sensitive nature of thrombolysis is critical for healthcare providers and patients.
  • Improving access and reducing delays in thrombolysis are essential for better patient care.